Live Breaking News & Updates on உச்சநிலை சிகிச்சை

Stay updated with breaking news from உச்சநிலை சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Montreal's Ventus Therapeutics raises $100-million to pursue 'Holy Grail' disease targets


Montreal’s Ventus Therapeutics raises $100-million to pursue ‘Holy Grail’ disease targets
Bookmark
Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file .
This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Marc Bruxelle/iStock Editorial / Getty Images
Ventus Therapeutics Inc. is the latest in a string of Canadian biotechnology startups to land significant funds from top North American investors.
The two-year-old Montreal company has raised US$100-million led by Boston-based RA Capital Management and backed by U.S. funds BVF Partners, Casdin Capital and Cormorant Asset Management, plus Fonds de solidarité FTQ, Canada’s leading institutional investor in the sector. ....

United States , Nova Scotia , British Columbia , San Francisco , Marc Bruxelle , Jerel Davis , Marcelo Bigal , Vertex Pharmaceuticals Inc , Ventus Therapeutics Inc , Merck Co , Alphabet Inc , Point Biopharma Inc , Teva Pharmaceuticals Industries Ltd , Boehringer Ingelheim International Gmb , Stock Editorial , North American , Casdin Capital , Cormorant Asset Management , Versant Ventures , Notch Therapeutics , Point Biopharma , Repare Therapeutics , Bluerock Therapeutics , Vertex Pharmaceuticals , Boehringer Ingelheim International Gmbh , Teva Pharmaceuticals Industries ,

Lifesciences BC's 6th Annual ACCESS TO INNOVATION Conference Will Generate Important Conversation Between R&D, Academia, Industry and Government


Press release content from Business Wire. The AP news staff was not involved in its creation.
Lifesciences BC’s 6th Annual ACCESS TO INNOVATION Conference Will Generate Important Conversation Between R&D, Academia, Industry and Government
February 22, 2021 GMT
A compelling and critical conversation will unfold over a two-day period at
February 24 – 25, 2021, will host thought leaders from health research & innovation, academia, industry, and government, as well as key individuals in the life science sector from across the country and abroad. The conversation is about therapeutic innovation, improving health and patient care, while supporting the post COVID-19 economic recovery of British Columbia. ....

United States , United Kingdom , British Columbia , Stephanie Willerth , Carl Hansen , Susan Ogilvie , James Taylor , Mark Caulfield , Kamran Shaikh , Greg Davignon , Abcellera Biologics , Allan Miranda , John Horgan , Ravi Kahlon , Peter Zandstra , Wendy Hurlburt , Ali Tehrani , Mary Ackenhusen , Pamela Fralick , Women Health Research Institute , University Of Victoria , Bc Centre For Disease , Communications External Affairs , Public Health , Bc Ministry Of Health , Canada Research ,

Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location

Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Peter Zandstra , University Of Toronto , Notch Therapeutics , Chief Scientific Officer Peter , Notch Photos , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , உச்சநிலை சிகிச்சை ,